By Ahmed Aboulenein WASHINGTON, Dec 18 (Reuters) - Americans enrolled in Medicare will pay about 50% less out of pocket in ...

"The noninferior effect of tirzepatide as compared with dulaglutide on the primary cardiovascular outcome provides additional ...

Shares in Tokyo-listed Nxera Pharma slid 5% at market open after Boehringer walked away from the neurological assets.

Boehringer Ingelheim launched the first-ever Catvocacy Forum for the company, uniting veterinarians to elevate cat care ...

Boehringer Ingelheim has turned down its chance to license Nxera Pharma’s phase 2-ready schizophrenia drug candidate, depriving the Japanese drugmaker of a 60 million euro ($70 million) option payment ...

Nxera Pharma, which recently announced a number of job cuts in Cambridge, is putting on a brave face after suffering another ...

Pharma marketers enter 2026 asking where DTC fits in the DTP era.  | Pharma marketers enter 2026 asking where DTC fits in the ...

Galux signed a research agreement with Boehringer Ingelheim to advance AI-driven precision protein design for next-generation ...

Pets Date Night, Boehringer Ingelheim’s signature event, celebrates the special bond between pets and their families and ...

Numab to receive milestone payment. BoehringerIngelheimhasadvanceditsnovelmulti-specificantibodyforretinal diseasesresultingfromacollaborationwithNumabintopreclinicaldevelopment.

Galux has signed a research agreement with Boehringer Ingelheim to jointly explore the application of AI in precision protein ...

AbbVie, Bristol Myers Squibb, Gilead, Merck and other drugmakers are expected on Friday afternoon ​to announce agreements ...